VANECK PHARMACEUTICAL ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.11 USD | -0.34% |
|
+0.68% | +7.06% |
Composition of VanEck Pharmaceutical ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
|---|---|---|---|---|---|---|
| 735 USD | -2.77% | +0.20% | +26.08% | 9.76% | ||
| 149.3 USD | -0.43% | +2.14% | -4.77% | 6.36% | ||
| 127.5 USD | -0.58% | -2.80% | +16.97% | 5.84% | ||
| 163.8 USD | +1.85% | +2.61% | +5.69% | 5.46% | ||
| 224 USD | -0.35% | -7.03% | +9.04% | 4.82% | ||
| 528.9 USD | -0.27% | -2.66% | +14.23% | 4.48% | ||
| 27.81 USD | +0.40% | +9.49% | -3.40% | 4.30% | ||
| 167.1 USD | -0.10% | +5.46% | -15.35% | 4.24% | ||
| 13.98 USD | -0.71% | +1.23% | +33.91% | 4.18% | ||
| 43.99 USD | +0.66% | -1.92% | -14.27% | 3.98% | ||
| 11.78 USD | +1.55% | +1.82% | +8.77% | 2.98% | ||
| 110 USD | +0.66% | +0.50% | -10.56% | 2.10% | ||
| 56.5 USD | +0.28% | +1.04% | +25.75% | 1.52% | ||
| 13.53 USD | +0.45% | +2.04% | -9.19% | 1.37% | ||
| 32.79 USD | -0.82% | +2.66% | +1.90% | 0.98% | ||
| 19.61 USD | +0.56% | +5.71% | +35.99% | 0.94% | ||
| 7.82 USD | -3.34% | -10.22% | -2.49% | 0.68% | ||
| 25.66 USD | +0.90% | -0.43% | -9.81% | 0.58% | ||
ETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
19/12/2011
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 27/03/2024 )
| AuM (EUR) | 503 M€ |
|---|---|
| AuM 1M | 475 M€ |
| AuM 3 months | 395 M€ |
| AuM 6 months | 407 M€ |
| AuM 12 months | 338 M€ |
- Stock Market
- ETF
- PPH ETF
- Components VanEck Pharmaceutical ETF - USD
